Gestational Hypertension Tied to Higher Later Risk for Cardiovascular Disease
By Lori Solomon HealthDay Reporter
MONDAY, Sept. 16, 2024 -- A self-reported history of gestational hypertension is associated with cardiovascular disease (CVD) in postmenopausal women, according to a study presented at the annual meeting of the Menopause Society, held from Sept. 10 to 14 in Chicago.
Marie Tan, from the Drexel University College of Medicine in Philadelphia, and colleagues surveyed 383 women presenting for mammogram screening to assess associations between a self-reported history of preeclampsia or eclampsia, gestational hypertension, and gestational diabetes with CVD outcomes in postmenopausal women.
The researchers found that 10.3 percent of women reported a history of CVD, while 2.8 percent reported a history of preeclampsia or eclampsia, 2.1 percent had a history of gestational hypertension, and 3.6 percent had a history of gestational diabetes. There was an association between self-reported history of gestational hypertension and CVD. While a numerically higher prevalence of CVD was seen in women with preeclampsia or eclampsia or all three adverse pregnancy outcomes, these associations were not statistically significant. No association was seen between gestational diabetes and CVD.
“Future research based on a larger sample size is needed to better understand the role adverse pregnancy outcomes may have in cardiovascular disease development and risk stratification," Tan said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2024
Read this next
Personality Tied to Cardiovascular Disease Risk With Type 2 Diabetes
TUESDAY, Sept. 17, 2024 -- Personality traits can influence cardiovascular disease (CVD) risk with type 2 diabetes mellitus (T2DM), according to a study published online Sept. 10...
Positive Airway Pressure Use Tied to Lower Cardiovascular Events
TUESDAY, Sept. 17, 2024 -- Positive airway pressure (PAP) utilization is associated with lower all-cause mortality and major adverse cardiovascular event (MACE) incidence in older...
Before and After Market Testing Rare for Cardiovascular Devices With Class I Recalls
TUESDAY, Sept. 17, 2024 -- Cardiovascular devices with Class I recalls appear to be rarely subjected to premarket or postmarket testing, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.